Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma

Multiple Myeloma is an incurable plasma cell malignancy with a poor survival rate that is usually treated with immunomodulatory drugs (iMiDs) and proteosome inhibitors (PIs). The malignant plasma cells quickly become resistant to these agents causing relapse and uncontrolled growth of resistant clon...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Travis S., Sudha, Parvathi, Liu, Enze, Blaney, Patrick, Morgan, Gareth, Chopra, Vivek S., Santos, Cedric Dos, Nixon, Michael, Huang, Kun, Suvannasankha, Attaya, Zaid, Mohammad Abu, Abonour, Rafat, Walker, Brian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462227/
https://www.ncbi.nlm.nih.gov/pubmed/37645789
http://dx.doi.org/10.21203/rs.3.rs-3221549/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462227/
https://www.ncbi.nlm.nih.gov/pubmed/37645789
http://dx.doi.org/10.21203/rs.3.rs-3221549/v1

Ejemplares similares